Literature DB >> 369590

Metamorphosis of chronic granulocytic leukaemia: diagnosis, classification, and management.

A S Spiers.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 369590     DOI： 10.1111/j.1365-2141.1979.tb03675.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.

Authors:  E Montefusco; G Alimena; F Lo Coco; M R De Cuia; Y Z Wang; M A Aloe Spiriti; F Mancini; M Cedrone; M Mancini; F Mandelli
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

Review 2.  Recent advances in haematology.

Authors:  D Samson; I Chanarin; C D Reid
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

Review 3.  Some aspects of immunological and cytochemical markers in leukemia.

Authors:  D Huhn
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Vindesine effect in myeloid leukemia.

Authors:  M Baccarani; A Zaccaria; G Corbelli; S Tura
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia.

Authors:  M Rozman; F Cervantes; C Rozman
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

6.  Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG).

Authors:  J A Gastaut; G Tell; P J Schechter; D Maraninchi; B Mascret; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 7.  European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Authors:  A Hochhaus; M Baccarani; R T Silver; C Schiffer; J F Apperley; F Cervantes; R E Clark; J E Cortes; M W Deininger; F Guilhot; H Hjorth-Hansen; T P Hughes; J J W M Janssen; H M Kantarjian; D W Kim; R A Larson; J H Lipton; F X Mahon; J Mayer; F Nicolini; D Niederwieser; F Pane; J P Radich; D Rea; J Richter; G Rosti; P Rousselot; G Saglio; S Saußele; S Soverini; J L Steegmann; A Turkina; A Zaritskey; R Hehlmann
Journal:  Leukemia       Date:  2020-03-03       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.